• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HER2 招募 AKT1 以破坏 STING 信号传导,从而抑制抗病毒防御和抗肿瘤免疫。

HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity.

机构信息

MOE Laboratory of Biosystems Homeostasis and Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, China.

Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Nat Cell Biol. 2019 Aug;21(8):1027-1040. doi: 10.1038/s41556-019-0352-z. Epub 2019 Jul 22.

DOI:10.1038/s41556-019-0352-z
PMID:31332347
Abstract

Sensing cytosolic DNA through the cGAS-STING pathway constitutes a widespread innate immune mechanism to monitor cellular damage and microbial invasion. Evading this surveillance is crucial in tumorigenesis, but the process remains largely unexplored. Here, we show that the receptor tyrosine kinase HER2 (also known as ErbB-2 or Neu) potently inhibits cGAS-STING signalling and prevents cancer cells from producing cytokines, entering senescence and undergoing apoptosis. HER2, but not EGFR, associates strongly with STING and recruits AKT1 (also known as PKB) to directly phosphorylate TBK1, which prevents the TBK1-STING association and TBK1 K63-linked ubiquitination, thus attenuating STING signalling. Unexpectedly, we observed that DNA sensing robustly activates the HER2-AKT1 axis, resulting in negative feedback. Accordingly, genetic or pharmacological targeting of the HER2-AKT1 cascade augments damage-induced cellular senescence and apoptosis, and enhances STING-mediated antiviral and antitumour immunity. Thus, our findings reveal a critical function of the oncogenic pathway in innate immune regulation and unexpectedly connect HER2-AKT1 signalling to the surveillance of cellular damage and antitumour immunity.

摘要

通过 cGAS-STING 途径感知细胞质 DNA 构成了广泛的先天免疫机制,用于监测细胞损伤和微生物入侵。逃避这种监测对于肿瘤发生至关重要,但这一过程在很大程度上仍未得到探索。在这里,我们表明受体酪氨酸激酶 HER2(也称为 ErbB-2 或 Neu)强烈抑制 cGAS-STING 信号转导,并阻止癌细胞产生细胞因子、进入衰老和凋亡。HER2 而非 EGFR 与 STING 强烈结合,并募集 AKT1(也称为 PKB)直接磷酸化 TBK1,从而阻止 TBK1-STING 结合和 TBK1 K63 连接的泛素化,从而减弱 STING 信号转导。出乎意料的是,我们观察到 DNA 感应强烈激活 HER2-AKT1 轴,导致负反馈。因此,HER2-AKT1 级联的遗传或药理学靶向增强了损伤诱导的细胞衰老和凋亡,并增强了 STING 介导的抗病毒和抗肿瘤免疫。因此,我们的发现揭示了致癌途径在先天免疫调节中的关键功能,并出人意料地将 HER2-AKT1 信号与细胞损伤和抗肿瘤免疫的监测联系起来。

相似文献

1
HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity.HER2 招募 AKT1 以破坏 STING 信号传导,从而抑制抗病毒防御和抗肿瘤免疫。
Nat Cell Biol. 2019 Aug;21(8):1027-1040. doi: 10.1038/s41556-019-0352-z. Epub 2019 Jul 22.
2
Inactivated cGAS-STING Signaling Facilitates Endocrine Resistance by Forming a Positive Feedback Loop with AKT Kinase in ER+HER2- Breast Cancer.失活的 cGAS-STING 信号通过与 ER+HER2- 乳腺癌中的 AKT 激酶形成正反馈环促进内分泌耐药。
Adv Sci (Weinh). 2024 Sep;11(35):e2403592. doi: 10.1002/advs.202403592. Epub 2024 Jul 18.
3
Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways.乙型肝炎病毒聚合酶破坏STING的K63连接的泛素化,以阻断先天性胞质DNA感应途径。
J Virol. 2015 Feb;89(4):2287-300. doi: 10.1128/JVI.02760-14. Epub 2014 Dec 10.
4
USP13 negatively regulates antiviral responses by deubiquitinating STING.USP13 通过去泛素化 STING 负调控抗病毒反应。
Nat Commun. 2017 May 23;8:15534. doi: 10.1038/ncomms15534.
5
The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.cGas-Sting 信号通路是先天免疫反应对抗细小病毒的必需条件。
Front Immunol. 2018 Jun 14;9:1297. doi: 10.3389/fimmu.2018.01297. eCollection 2018.
6
STING dependent sensing - Does HIV actually care?STING 依赖性感应——HIV 真的在意吗?
Cytokine Growth Factor Rev. 2018 Apr;40:68-76. doi: 10.1016/j.cytogfr.2018.03.002. Epub 2018 Mar 9.
7
HER2 joins AKT to inhibit STING immunity.人表皮生长因子受体2(HER2)与蛋白激酶B(AKT)共同作用以抑制干扰素基因刺激蛋白(STING)介导的免疫反应。
Nat Cell Biol. 2019 Aug;21(8):917-918. doi: 10.1038/s41556-019-0368-4.
8
HTLV-1 Tax impairs K63-linked ubiquitination of STING to evade host innate immunity.人嗜T淋巴细胞病毒1型(HTLV-1)的Tax蛋白损害干扰素基因刺激蛋白(STING)的K63连接的泛素化,以逃避宿主的天然免疫。
Virus Res. 2017 Mar 15;232:13-21. doi: 10.1016/j.virusres.2017.01.016. Epub 2017 Jan 22.
9
Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.cGAS/STING缺陷小鼠对腺病毒载体的先天性抗病毒反应减弱,对适应性免疫的影响最小。
J Virol. 2016 Jun 10;90(13):5915-27. doi: 10.1128/JVI.00500-16. Print 2016 Jul 1.
10
Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus.SUMOylation 促进 DNA 传感器 cGAS 和衔接蛋白 STING 的稳定性,以调节对 DNA 病毒的反应动力学。
Immunity. 2016 Sep 20;45(3):555-569. doi: 10.1016/j.immuni.2016.08.014. Epub 2016 Sep 13.

引用本文的文献

1
Tumor-derived PRMT1 suppresses macrophage antitumor activity by inhibiting cGAS/STING signaling in gastric cancer cells.肿瘤来源的PRMT1通过抑制胃癌细胞中的cGAS/STING信号通路来抑制巨噬细胞的抗肿瘤活性。
Cell Death Dis. 2025 Aug 26;16(1):649. doi: 10.1038/s41419-025-07960-y.
2
CAD hijacks STING to impair antitumor immunity and radiotherapy efficacy of colorectal cancer.冠状动脉疾病劫持干扰素基因刺激蛋白以削弱结直肠癌的抗肿瘤免疫和放射治疗效果。
Cell Death Dis. 2025 Aug 23;16(1):641. doi: 10.1038/s41419-025-07964-8.
3
Novel anti-HER2 nanobody-drug conjugates with enhanced penetration of solid tumor and BBB, reduced systemic exposure and superior antitumor efficacy.
新型抗HER2纳米抗体-药物偶联物,具有增强的实体瘤和血脑屏障穿透能力、降低的全身暴露水平以及卓越的抗肿瘤疗效。
Acta Pharmacol Sin. 2025 Aug 18. doi: 10.1038/s41401-025-01634-3.
4
HER2 and urothelial carcinoma: current understanding and future directions.人表皮生长因子受体2(HER2)与尿路上皮癌:当前认识与未来方向
Nat Rev Urol. 2025 Aug 15. doi: 10.1038/s41585-025-01075-x.
5
Fighting HER2 in Gastric Cancer: Current Approaches and Future Landscapes.胃癌中针对人表皮生长因子受体2(HER2)的治疗:当前方法与未来前景
Int J Mol Sci. 2025 Jul 28;26(15):7285. doi: 10.3390/ijms26157285.
6
Unveiling cGAS mechanisms: Insights into DNA damage and immune sensing in cancer.揭示cGAS机制:对癌症中DNA损伤与免疫传感的见解
DNA Repair (Amst). 2025 Jul 9;152:103868. doi: 10.1016/j.dnarep.2025.103868.
7
Carriers Multimerize STING Protein Fragments to Activate Type I Interferon Signaling in STING-Deficient Cancer Cells.载体使STING蛋白片段多聚化以激活STING缺陷癌细胞中的I型干扰素信号传导。
Mol Pharm. 2025 Aug 4;22(8):4632-4650. doi: 10.1021/acs.molpharmaceut.5c00226. Epub 2025 Jul 6.
8
Next-Generation HER-2 Tumor-Targeted Delivery of the STING Agonist Immune-Stimulating Antibody Conjugate (ISAC) Improves Anticancer Efficacy and Induces Immunological Memory.下一代HER-2肿瘤靶向递送的STING激动剂免疫刺激抗体偶联物(ISAC)可提高抗癌疗效并诱导免疫记忆。
MedComm (2020). 2025 Jul 2;6(7):e70254. doi: 10.1002/mco2.70254. eCollection 2025 Jul.
9
Downregulation of cGAS/STING expression in tumor cells by cancer-associated fibroblasts in colorectal cancer.结直肠癌中癌相关成纤维细胞对肿瘤细胞中cGAS/STING表达的下调作用
Sci Rep. 2025 Jun 2;15(1):19234. doi: 10.1038/s41598-025-03924-6.
10
cGAS-STING signaling in melanoma: regulation and therapeutic targeting.黑色素瘤中的cGAS-STING信号传导:调控与治疗靶点
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 14. doi: 10.1007/s00210-025-04141-8.